PIQ-Pharma Group

PIQ-PHARMA is a prominent Russian pharmaceutical group established in 1994 that integrates drug development, manufacturing, and marketing. The company specializes in creating high-quality medications for neurology, cardiology, endocrinology, and pediatrics. Its portfolio features several market-leading brands, including the nootropic Pantogam and the metabolic agent Elkar. PIQ-PHARMA maintains a robust infrastructure comprising the PIQ-PHARMA TECH R&D center and the PIQ-PHARMA LEK manufacturing site, which operates under GMP standards. The group focuses on both innovative proprietary molecules and high-quality generics to address unmet medical needs in the Russian and CIS markets.